MDK - Trading SA

MDK - Trading reported total assets of 510,047 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Apr 2026).

Company number (CBE) 0479.135.953 · VAT BE0479135953
8830 Hooglede
active in Business and other management consultancy activities (NACE 70200)
operating since 24 Dec 2002 (≈ 24 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of MDK - Trading shows with a free account.

See the score
Profile
SA since 2002
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result1,957 €
Equity308,336 €
Cash102,550 €
EBITDA41,698 €
Total assets510,047 €
The line marks its sector median: 58.4% (26338 companies).

Change 2022 → 2025: Equity +19 % Total assets +8 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

MDK - Trading's annual accounts

20252024202320222021
Net result1,957 €
Equity308,336 €
Cash102,550 €
EBITDA41,698 €
Total assets510,047 €

Filed annual accounts

  • Year ended 30 Sep 2025filed on 28 Apr 2026
  • Year ended 30 Sep 2024filed on 28 Apr 2025
  • Year ended 30 Sep 2023filed on 23 Apr 2024
  • Year ended 30 Sep 2022filed on 21 Apr 2023
  • Year ended 30 Sep 2021filed on 12 Apr 2022

MDK - Trading's financial analysis

Management and control of MDK - Trading

2 active director(s) in the register.

MDK - Trading's shareholders and holdings →

MDK - Trading's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0479.135.953
VAT number
BE0479135953
Peppol
Registered · 0208:0479135953 · as of 10 Nov 2026
Legal form
SA
Incorporated
24 Dec 2002
Registered office
8830 Hooglede
Latest accounts
2025 · filed on 28 Apr 2026
Activity
Business and other management consultancy activities (NACE 70200)

MDK - Trading (SA) has been based in Hooglede since 2002, active in: business and other management consultancy activities. For 2025, it reports a net profit of 1,957 € and equity of 308,336 €; its revenue is not published. Its solvency stands at 60.5%, above the median of its sector (58.4%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to MDK - Trading

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about MDK - Trading

What is the revenue of MDK - Trading?

MDK - Trading files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of MDK - Trading?

In Belgium, the VAT number is the company number prefixed with BE: BE0479135953 for MDK - Trading, if the company is VAT-registered. Its company number (CBE) is 0479.135.953.

Where is the registered office of MDK - Trading?

According to the CBE register, the registered office of MDK - Trading is in 8830 Hooglede.

What is the equity of MDK - Trading?

At the close of the 2025 financial year, the equity of MDK - Trading amounts to 308,336 €, a solvency of 60.5% of total assets.

Who manages MDK - Trading?

The register lists 2 active mandates at MDK - Trading. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of MDK - Trading

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 06 Jul 2026

No credit card, no commitment.

What each plan unlocks →